Randomized phase II trial of BCDT (carmustine, cisplatin, dacarbazine and tamoxifen) with or without interferon alpha and interleukin-2 in patients with metastatic melanoma
Search this article
Journal
-
- Br. J. Cancer
-
Br. J. Cancer 77 1280-1286, 1998
- Tweet
Details 詳細情報について
-
- CRID
- 1570572700103687936
-
- NII Article ID
- 10013030503
-
- NII Book ID
- AA00574355
-
- Data Source
-
- CiNii Articles